SUNNYVALE, Calif.--(BUSINESS WIRE)--With expiring patents and growing gaps in revenue a reality in today’s global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive. With greater frequency, pharmaceutical firms are seeking new sources that can deliver key inputs such as active pharmaceutical
For more information, please visit
http://www.businesswire.com/news/home/20090901005015/en